Omid Beiki
Overview
Explore the profile of Omid Beiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarebanhassanabadi M, Shahriari Kalantari M, Boffetta P, Beiki O, Pakseresht M, Sarrafzadegan N, et al.
Diabetes Metab Syndr
. 2020 Aug;
14(5):1391-1397.
PMID: 32755840
Background And Objective: Overweight and obesity are thought to be associated with increased risk of chronic disease in the Middle East. The present study aimed to determine the association between...
2.
Hassanabadi M, Mirhosseini S, Mirzaei M, Namayandeh S, Beiki O, Gannar F, et al.
Int J Prev Med
. 2020 May;
11:33.
PMID: 32363020
Background: Metabolic syndrome (MetS) is one of the world's largest health epidemics, and its management is a major challenge worldwide. The aim of this 10-year follow-up study was to assess...
3.
Shahin S, Eskandarieh S, Naser Moghadasi A, Razazian N, Baghbanian S, Ashtari F, et al.
Mult Scler Relat Disord
. 2019 Jun;
33:158-161.
PMID: 31203146
Background: As the prevalence and incidence of Multiple Sclerosis (MS) are increasing remarkably in Iran, gathering standardized information regarding the individual's diagnosis, care, and outcomes through a uniform registry system...
4.
Beiki O, Frumento P, Bottai M, Manouchehrinia A, Hillert J
JAMA Neurol
. 2019 Mar;
76(6):665-671.
PMID: 30882868
Importance: Clinicians' experience and findings from recent natural history studies suggest that multiple sclerosis (MS) may now be running a more slowly progressing course than before. Objective: To investigate whether...
5.
Sheikhtaheri A, Nahvijou A, Sedighi Z, Hadji M, Golmahi M, Roshandel G, et al.
Int J Med Inform
. 2018 Jul;
117:26-32.
PMID: 30032962
Objective: Several methods have been suggested for evaluation of population-based cancer registries (PBCR) worldwide. However, most of these methods evaluate the data and outputs of the cancer registries. This study...
6.
Filippini G, Del Giovane C, Clerico M, Beiki O, Mattoscio M, Piazza F, et al.
Cochrane Database Syst Rev
. 2017 Apr;
4:CD012200.
PMID: 28440858
Background: The treatment of multiple sclerosis has changed over the last 20 years. The advent of disease-modifying drugs in the mid-1990s heralded a period of rapid progress in the understanding...
7.
Manouchehrinia A, Beiki O, Hillert J
Mult Scler
. 2016 Dec;
23(11):1488-1495.
PMID: 27956559
Background: The course of multiple sclerosis (MS) has been studied in several cohorts; however, results have varied significantly. Objective: To describe the clinical course of MS in a nationwide cohort...
8.
Kavaliunas A, Manouchehrinia A, Stawiarz L, Ramanujam R, Agholme J, Hedstrom A, et al.
Mult Scler
. 2016 Oct;
23(9):1233-1240.
PMID: 27754943
Objectives: The aim of this study was to identify factors influencing the long-term clinical progression of multiple sclerosis (MS). A special objective was to investigate whether early treatment decisions influence...
9.
Aznab M, Beiki O, Pia K, Setayeshi K, Hesami M, Vrae H
J Gastrointest Cancer
. 2016 Aug;
48(1):31-37.
PMID: 27543101
Aim: Our aim was to evaluate impact of chemotherapy (5-fluorouracil plus docetaxel and cisplatin) on the survival of gastric cancer cases. Method: Seventy-nine patients were eligible to take part in...
10.
Tahvilian R, Ebrahimi A, Beiki O, Nemati H, Masoud S
J Drug Assess
. 2016 Aug;
4(1):12-8.
PMID: 27536457
Objective: Hirsutism is the presence of excess terminal hairs in females in a male-like pattern. The most accepted hypothesis for the development of hirsutism is increased 5α-reductase activity in hair...